Patents by Inventor Andrew Douglas PENMAN

Andrew Douglas PENMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11740202
    Abstract: The presence of biomarkers or other analytes can be detected in the bodily fluid using Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (ECS) in devices, such as handheld point-of-care devices. The devices, as well as systems and methods, utilize using Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (EIS) in combination with an antibody or other target-capturing molecule on a working electrode. Imaginary impedance or phase shift, as well as background subtraction, also may be utilized.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: August 29, 2023
    Assignee: ADVANCED TEAR DIAGNOSTICS, LLC.
    Inventors: Andrew Douglas Penman, Marcus Willard Smith, Catalina Valencia, Sergei A Svarovsky
  • Publication number: 20230120990
    Abstract: The presence of biomarkers or other analytes can be detected in the bodily fluid using Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (ECS) in devices, such as handheld point-of-care devices. The devices, as well as systems and methods, utilize using Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (EIS) in combination with an antibody or other target-capturing molecule on a working electrode. Imaginary impedance or phase shift, as well as background subtraction, also may be utilized.
    Type: Application
    Filed: July 28, 2022
    Publication date: April 20, 2023
    Inventors: Andrew Douglas PENMAN, Marcus Willard SMITH, Catalina VALENCIA, Sergei A SVAROVSKY
  • Publication number: 20190072545
    Abstract: The presence of biomarkers or other analytes can be detected in the bodily fluid using Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (ECS) in devices, such as handheld point-of-care devices. The devices, as well as systems and methods, utilize using Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (EIS) in combination with an antibody or other target-capturing molecule on a working electrode. Imaginary impedance or phase shift, as well as background subtraction, also may be utilized.
    Type: Application
    Filed: September 4, 2018
    Publication date: March 7, 2019
    Inventors: Andrew Douglas PENMAN, Marcus Willard SMITH, Catalina VALENCIA, Sergei A. SVAROVSKY
  • Publication number: 20190072560
    Abstract: The presence of biomarkers or other analytes can be detected in the bodily fluid using Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (ECS) in devices, such as handheld point-of-care devices. The devices, as well as systems and methods, utilize using Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (EIS) in combination with an antibody or other target-capturing molecule on a working electrode. Imaginary impedance or phase shift, as well as background subtraction, also may be utilized.
    Type: Application
    Filed: August 31, 2018
    Publication date: March 7, 2019
    Inventors: Andrew Douglas PENMAN, Marcus Willard SMITH, Catalina VALENCIA, Sergei A. SVAROVSKY